Introduction
Acute Lymphoblastic Leukaemia (ALL) is a fast-growing type of blood cancer that affects the bone marrow and white blood cells. It occurs when the body produces a large number of immature lymphocytes (a type of white blood cell) that do not function properly.
Because ALL progresses rapidly, early diagnosis and immediate treatment are critical. Without treatment, the disease can spread quickly to the blood, lymph nodes, spleen, liver, brain, and spinal cord.
The good news is that Acute Lymphoblastic Leukaemia is one of the most treatable and often curable types of leukaemia, especially in children. With modern therapies such as chemotherapy, targeted therapy, immunotherapy, and bone marrow transplant (BMT), survival rates have improved significantly.
India has become a trusted destination for advanced, affordable ALL treatment, offering world-class leukaemia care at significantly lower costs than in Western countries.
What Is Acute Lymphoblastic Leukaemia (ALL)?
Acute Lymphoblastic Leukaemia is a cancer of the blood and bone marrow that begins in immature lymphocytes (B-cells or T-cells).
In a healthy body:
- Bone marrow produces mature, functioning blood cells.
- White blood cells help fight infections.
In ALL:
- Immature lymphoblasts multiply uncontrollably.
- These abnormal cells crowd out healthy red blood cells, platelets, and normal white blood cells.
- The immune system becomes weak.
- Anaemia and bleeding complications develop.
“Acute” means the disease progresses quickly and requires urgent medical attention.
Who Is at Risk for ALL?
ALL can occur at any age, but is most common in:
- Children under 15 years
- Adults over 50 years
Risk factors may include:
- Genetic disorders (e.g., Down syndrome)
- Previous chemotherapy or radiation
- Family history of leukaemia
- Exposure to high radiation
In many cases, the exact cause remains unknown.
Early Symptoms of Acute Lymphoblastic Leukaemia
The early signs of ALL may resemble common infections or flu-like symptoms, which is why they are often overlooked.
Common symptoms include:
- Persistent fatigue and weakness
- Frequent infections
- Fever without obvious cause
- Pale skin (due to anaemia)
- Easy bruising or bleeding
- Nosebleeds or gum bleeding
- Bone or joint pain
- Swollen lymph nodes
- Enlarged spleen or liver
- Unexplained weight loss
Children may complain of leg pain or refuse to walk due to discomfort in their bones.
If symptoms persist for more than two weeks, medical evaluation is essential.
How Is Acute Lymphoblastic Leukaemia Diagnosed?
Early and accurate diagnosis improves treatment outcomes.
1️⃣ Complete Blood Count (CBC)
Detects abnormal white blood cell levels and anaemia.
2️⃣ Peripheral Blood Smear
Examine blood cells under a microscope.
3️⃣ Bone Marrow Biopsy
Confirms the presence of leukaemia cells.
4️⃣ Flow Cytometry
Identifies whether ALL is B-cell or T-cell type.
5️⃣ Genetic Testing
Detects chromosomal abnormalities such as:
- Philadelphia chromosome (Ph+ ALL)
- Other high-risk mutations
These tests guide personalised treatment planning.
Treatment Options for Acute Lymphoblastic Leukaemia
Treatment for ALL is divided into phases and may last 2–3 years.
1️⃣ Induction Therapy
Goal: Achieve remission (eliminate visible leukaemia cells).
Duration: 4–6 weeks.
Includes combination chemotherapy.
2️⃣ Consolidation Therapy
Destroys remaining leukaemia cells to prevent relapse.
3️⃣ CNS Prophylaxis
Prevents leukaemia from spreading to the brain and spinal cord.
Includes intrathecal chemotherapy.
4️⃣ Maintenance Therapy
Low-dose chemotherapy for 2–3 years to maintain remission.
When is a bone marrow transplant needed in ALL?
Bone Marrow Transplant (BMT) may be recommended in:
- High-risk genetic cases
- Poor response to chemotherapy
- Relapsed ALL
- Adult patients with aggressive disease
BMT replaces diseased bone marrow with healthy stem cells and offers a chance for a long-term cure.
Advanced Treatment Options in India
India offers modern therapies, including:
- Multi-phase chemotherapy protocols
- Targeted therapy (for Ph+ ALL)
- Immunotherapy
- CAR T-cell therapy for relapsed ALL
- Bone marrow transplant (autologous & allogeneic)
With internationally trained haematologists and advanced transplant units, India provides high survival rates at affordable costs.
Cost of Acute Lymphoblastic Leukaemia Treatment in India
Treatment costs depend on:
- Type of therapy
- Length of treatment
- Whether a transplant is needed
Approximate costs:
- Chemotherapy (complete protocol): $5,000 – $15,000
- Bone Marrow Transplant: $25,000 – $35,000
- CAR T-cell therapy (India-made): $35,000 – $45,000
Compared to the US or UK, India offers savings of 60–80% without compromising quality.
Is Acute Lymphoblastic Leukaemia Curable?
Yes.
- Children: Cure rates exceed 85–90%
- Adults: Outcomes vary but improve with targeted therapy and transplant
- Early diagnosis significantly improves survival
With proper treatment, many patients achieve long-term remission and normal life expectancy.
Expert Leukaemia Care in India
One of India’s leading haematologists in leukaemia and bone marrow transplant is:
Dr. Rahul Bhargava
With over 25 years of experience in treating complex blood cancers, he specialises in:
- Acute leukaemia’s
- High-risk ALL
- Bone marrow transplantation
- CAR T-cell therapy
His patient-centred approach ensures personalised leukaemia care for both domestic and international patients.
Frequently Asked Questions
What is Acute Lymphoblastic Leukaemia?
ALL is a fast-growing blood cancer affecting immature white blood cells in the bone marrow.
What are the early symptoms of ALL?
Fatigue, infections, bruising, fever, bone pain, and swollen lymph nodes.
Is ALL curable?
Yes. It has high cure rates, especially in children.
When is a bone marrow transplant required in ALL?
In high-risk, relapsed, or chemotherapy-resistant cases.
How long does ALL treatment take?
Treatment may last 2–3 years, including maintenance therapy.
